---
$id: https://graph.org.ai/products/commodity/51141509
$type: Product
source: UNSPSC
code: "51141509"
title: "Vigabatrin"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vigabatrin

**UNSPSC Code**: 51141509
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C6H11NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GR120KRT6K, chemically known as 5-hexenoic acid, 4-amino- but generally known as vigabatrin, which bears US NIH Compound Identifier 5665. European Medicines Agency schedules Vigabatrin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00048MIG. The term VIGABATRIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules vigabatrin in its Anatomical Therapeutic Chemical (ATC) Classification. VIGABATRIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule vigabatrin under HS 29224995 and SITC 51465. As of Q4 2014, VIGABATRIN remains the US FDA Preferred Term for this commodity. Vigabatrin bears US NLM identifiers UMLS ID C0048044 and NCI Concept Code C87611. SMILES: OC(=O)CCC(N)C=C.

